<bill session="115" type="h" number="5202" updated="2019-04-18T16:20:57Z">
  <state datetime="2018-05-09">REPORTED</state>
  <status>
    <unknown datetime="2018-05-09"/>
  </status>
  <introduced datetime="2018-03-07"/>
  <titles>
    <title type="official" as="introduced">To amend the Controlled Substances Act to provide for the delivery of a controlled substance by a pharmacy to an administering practitioner.</title>
    <title type="short" as="introduced">Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018</title>
    <title type="short" as="introduced">Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018</title>
    <title type="display">Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018</title>
  </titles>
  <sponsor bioguide_id="C001106"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2018-05-09"/>
    <cosponsor bioguide_id="H001078" joined="2018-03-15"/>
    <cosponsor bioguide_id="N000127" joined="2018-03-07"/>
    <cosponsor bioguide_id="R000603" joined="2018-03-22"/>
    <cosponsor bioguide_id="S001196" joined="2018-03-15"/>
    <cosponsor bioguide_id="T000478" joined="2018-06-12"/>
    <cosponsor bioguide_id="W000791" joined="2018-05-22"/>
  </cosponsors>
  <actions>
    <action datetime="2018-03-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-03-07" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-03-07">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-03-09">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-04-06">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
    <action datetime="2018-04-25">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2018-04-25">
      <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
    </action>
    <action datetime="2018-05-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-09" state="REPORTED">
      <text>Ordered to be Reported by Voice Vote.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Markup, Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="" code="HSJU" name="House Judiciary" activity="Referral"/>
    <committee subcommittee="Crime, Terrorism, and Homeland Security" code="HSJU08" name="House Judiciary" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="unknown" number="2680"/>
    <bill type="s" session="115" relation="unknown" number="916"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Government studies and investigations"/>
    <term name="Health personnel"/>
  </subjects>
  <amendments/>
  <summary date="2018-03-07T05:00:00Z" status="Introduced in House">Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump.

The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.</summary>
  <committee-reports/>
</bill>
